WILLIAM BLAIR INVESTMENT MANAGEMENT LLC 13D and 13G filings for Ligand Pharmaceuticals Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 1:53 pm Sale | 2022-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | WILLIAM BLAIR INVESTMENT MANAGEMENT LLC | 141,128 0.800% | -2,103,619 (-93.71%) | Filing |
| 2022-02-09 6:54 pm Purchase | 2021-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | WILLIAM BLAIR INVESTMENT MANAGEMENT LLC | 2,244,747 8.400% | 193,631 (+9.44%) | Filing |
| 2021-05-07 3:55 pm Sale | 2021-04-30 | 13G | Ligand Pharmaceuticals Incorporated LGND | WILLIAM BLAIR INVESTMENT MANAGEMENT LLC | 2,051,115 7.700% | -1,220,680 (-37.31%) | Filing |
| 2021-02-11 2:54 pm Purchase | 2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | WILLIAM BLAIR INVESTMENT MANAGEMENT LLC | 3,271,795 12.700% | 233,511 (+7.69%) | Filing |
| 2020-10-08 09:17 am Purchase | 2020-09-30 | 13G | Ligand Pharmaceuticals Incorporated LGND | WILLIAM BLAIR INVESTMENT MANAGEMENT LLC | 3,038,285 11.800% | 767,074 (+33.77%) | Filing |